reticulum which stimulate Ca2+ transport across these membrane systems (Katz et al., 1975; Will et al., 1973; Wollenberger & Will, 1978) . In the sarcoplasmic reticulum a protein of M , 11 OOO, called phospholamban, is phosphorylated by cyclic AMP-and Ca*+-dependent protein kinases (Katz et al., 1975; Le Peuch et al., 1980) . In the sarcolemma a number of proteins have been reported to be phosphorylated, although there is now good evidence that phospholamban, or a very similar protein, is also present as a major phosphoprotein in this membrane fraction. In our laboratory a mixed sarcoplasmic reticulum and sarcolemma membrane fraction from rat hearts perfused with )*Pi contained one major phosphoprotein which co-migrated with authentic phospholamban. Phosphorylation was increased lG15-fold by perfusion with catecholamine, and the increase in phosphorylation just preceded the increase in contractile force. A highly purified sarcoplasmic reticulum fraction prepared from this mixed membrane preparation surprisingly contained phospholamban in a dephosphorylated form, although phosphorylated phospholamban was present in a less pure sarcolemma preparation. We tentatively conclude that in rat heart, at least part of the sarcoplasmic reticulum contains phospholamban which is not phosphorylated in response to catecholamines. In contrast, the sarcolemma contains phospholamban or a very similar protein which is phosphorylated, under these conditions. These results imply that much of the regulation of cytoplasmic Ca2+ in the presence of catecholamine may occur at the sarcolemma.
There are two major contractile proteins in heart muscle that are phosphorylated in response to catecholamines and other agents which elevate cyclic AMP, namely troponin-I and C-protein (England, 1975 (England, , 1976 Jeacocke & England, 1980~) . Both of these proteins when isolated are good substrates for cyclic AMP-dependent protein kinase (Cole & Perry, 1975; Ray & England, 1976) . Recent studies in our laboratory have shown that C-protein may be rapidly phosphorylated in vitro or in vivo on four to five sites, and that C-protein is phosphorylated by cyclic AMP-protein kinase at a 2-3-fold higher rate than is troponin-I. Both of these proteins are phosphorylated to a low extent in control perfused hearts, and following catecholamine administration they are both phosphorylated over a time course similar to that of the increase in contraction. Phosphorylation of troponin decreases the Ca*+-sensitivity of either isolated cardiac myofibrils (Ray & England, 1976) or skinned cardiac fibres (Mope et al., 1980) , and increase the rate of dissociation of Ca2+ from troponin (Robertson et al., 1982) . The function of troponin-I phosphorylation is therefore most probably involved in the increased rate of relaxation of heart muscle caused by catecholamines. The function of both C-protein itself, and its phosphorylation, are at present unknown.
Following a pulse of catecholamine both C-protein and troponin-I remain phosphorylated for many minutes, although the contractile response rapidly returns to normal (England, 1976; Stull et al., 1981) . In contrast, phosphorylase a is rapidly dephosphorylated under these conditions. We have examined VOl. 11 the phosphoprotein phosphatases in rat heart muscle and find four or five different molecular forms. One of these is specific for phosphorylase a, while another seems to dephosphorylate proteins phosphorylated by cyclic AMP-dependent protein kinase. There are in addition at least two broad specificity activities. These results may explain how proteins may be dephosphorylated at different rates, but as yet we do not know why the phosphatase(s) for troponin-I and C-protein are not active following catecholamine stimulation. The phosphorylated inhibitor-1 (Huang & Glinsmann, 1976 ) is absent from rat heart, so this control mechanism cannot 'be operating. Dephosphorylation can be stimulated in perfused hearts by cholinergic agents (England, 1976; Hartzell & Titus, 1982) , which increase cyclic GMP, but a direct causal relationship between cyclic GMP and dephosphorylation has yet to be established.
Myosin P-light chain is phosphorylated by a specific, Ca2+-stimulated kinase and dephosphorylated by a specific phosphatase (Frearson & Perry, 1975; Morgan et al., 1976) . Under control conditions of the level of phosphorylation is approx. 0.5 mol of phosphate per mol of P-light chain in hearts of several species, and this is unchanged by a number of acute inotropic interventions (Holroyde et al., 1979; Jeacocke & England, 1980b; High & Stull, 1980; Westwood & Perry, 1981) . It is also constant during changes in myosin enzyme patterns induced by altered thyroid states (Litten et al., 1981) . However, both the myosin light chain kinase and phosphatase are active in heart. Perfusion with 32P, (Jeacocke & England, 1980b ) permits calculation of the rate of turnover of phosphate in the P-light chains of rat heart. A value of t+ of approx. 3min was found, under conditions where there was no net change in total phosphate content. A possible explanation for the failure of positive inotropic agents to increase the phosphorylation of P-light chain is that under normal conditions the kinase is fully activated by the level of Ca2+ present, and no further increase in activity can occur when the cytoplasmic Ca2+ is elevated (Stull et al., 1981) . These observations indicate the P-light chain phosphorylation cannot be of importance in the short-term regulation of cardiac contractility.
